FTC sues important pharmacy gain administrators about insulin prices The company introduced action in opposition to Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating procedures “artificially inflated” the checklist price of life-saving insulin prescription drugs. Elevance lowers guidance on ‘unparalleled’ Medicaid difficulties Executives stat... https://ayahealthcareaddress61615.blogdun.com/31238356/indicators-on-healthcare-news-you-should-know